Requires comprehensive coverage for treatment of obesity, including coverage for prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medication.
Summary
Bill S03104 aims to amend the social services law and the insurance law in New York to mandate comprehensive coverage for the treatment of obesity. This includes provisions for prevention and wellness services, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medications. The bill stipulates that coverage for these services must not be more restrictive than the FDA-approved indications for such treatments and must be treated equally to other medical conditions regarding deductibles and copayments.
The legislation requires that all insurance policies providing medical coverage must include these obesity treatment services, ensuring that individuals seeking help for obesity have access to necessary medical interventions without facing additional barriers. Insurers are also mandated to provide written notice to covered persons about the coverage requirements, ensuring transparency and awareness of available benefits.
The bill is set to take effect 180 days after it becomes law, applying to any policy issued, delivered, renewed, or modified after that date. This timeline allows for insurers to adjust their policies and inform their members of the new coverage requirements.
Overall, the bill seeks to address the growing public health issue of obesity by facilitating access to comprehensive treatment options, thereby potentially improving health outcomes for affected individuals in New York State.
Impact
If enacted, Bill S03104 would significantly change the landscape of health insurance coverage for obesity treatment in New York. It would require all relevant insurance policies to include comprehensive coverage for obesity treatment, which could lead to increased access to necessary medical services for individuals struggling with obesity. This could also result in a shift in how obesity is perceived within the healthcare system, treating it with the same importance as other medical conditions. The bill may also influence healthcare costs and insurance premiums as insurers adjust to the new coverage mandates.
Sentiment
The sentiment surrounding Bill S03104 appears to be generally supportive, as it addresses a critical public health issue and aims to improve access to necessary treatments for obesity. However, there may be concerns from some stakeholders regarding the potential impact on insurance premiums and the overall cost of healthcare. Discussions in committee and among legislators may reflect a balance between the need for comprehensive coverage and the financial implications for insurers and consumers.
Contention
Notable points of contention may arise from insurance providers who could be concerned about the financial implications of mandated comprehensive coverage for obesity treatment. Some may argue that such requirements could lead to increased premiums or administrative burdens. On the other hand, advocates for public health and obesity treatment may emphasize the importance of access to these services for improving health outcomes and reducing long-term healthcare costs associated with obesity-related conditions.
Same As
Requires comprehensive coverage for treatment of obesity, including coverage for prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medication.
Requires comprehensive coverage for treatment of obesity, including coverage for prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medication.
Requires Medicaid to provide comprehensive coverage for the treatment of obesity including coverage for intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medication.
Authorizes office of health and human services (EOHHS) to establish coverage for obesity treatments, including medication. Office of health and human services would seek a 1115(a) waiver.
A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions. (Formerly HSB 25.) Effective date: 03/28/2025.
A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(See SF 305.)
A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(See HF 182.)